Michela Helga Falzone

2PUBLICATIONS
9CO-AUTHORS
Immunogenetics (incl. genetic immunology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 30, 2025
IL10 rs1800896 Genetic Variant Predicts Biochemical Remission in Inflammatory Bowel Disease Patients Undergoing Biologic Therapy.

Michela Helga Falzone, Davide Giuseppe Ribaldone, Martina Buglione

|Apr 27, 2024
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study.

Jessica Cusato, Davide Giuseppe Ribaldone, Michela Helga Falzone

Pageof 1

Frequent Collaborators

2 joint publications

Davide Giuseppe Ribaldone

1 joint publications

Jessica Cusato

1 joint publications

Alessandra Manca

1 joint publications

Alice Palermiti

1 joint publications

Giorgio Maria Saracco

1 joint publications

Francesco Costa

1 joint publications

Gian Paolo Caviglia

1 joint publications

Antonio D'Avolio

1 joint publications

Francesca Saba

Frequent Collaborators

2 joint publications

Davide Giuseppe Ribaldone

1 joint publications

Jessica Cusato

1 joint publications

Alessandra Manca

1 joint publications

Alice Palermiti

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

2.1K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos

Top Related Videos

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

2.1K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on : Jan 29, 2019

10.1K
See more related videos